ACCELERATED PUBLICATION
The Notch Ligands, Delta1 and Jagged2, Are Substrates for Presenilin-dependent "gamma -Secretase" Cleavage*

Takeshi IkeuchiDagger and Sangram S. Sisodia§

From the Department of Neurobiology, Pharmacology, and Physiology, The University of Chicago, Chicago, Illinois 60637

Received for publication, December 30, 2002, and in revised form, January 16, 2003

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The evolutionary conserved Notch signaling pathway is involved in cell fate specification and mediated by molecular interactions between the Notch receptors and the Notch ligands, Delta, Serrate, and Jagged. In this report, we demonstrate that like Notch, Delta1 and Jagged2 are subject to presenilin (PS)-dependent, intramembranous "gamma -secretase" processing, resulting in the production of soluble intracellular derivatives. Moreover, and paralleling the observation that expression of familial Alzheimer's disease-linked mutant PS1 compromises production of Notch S3/NICD, we show that the PS-dependent production of Delta1 cytoplasmic derivatives are also reduced in cells expressing mutant PS1. These studies led us to conclude that a similar molecular apparatus is responsible for intramembranous processing of Notch and it's ligands. To assess the potential role of the cytoplasmic derivative on nuclear transcriptional events, we expressed a Delta1-Gal4VP16 chimera and demonstrated marked transcriptional stimulation of a luciferase-based reporter. Our findings offer the proposal that Delta1 and Jagged2 play dual roles as activators of Notch receptor signaling and as receptors that mediate nuclear signaling events via gamma -secretase-generated cytoplasmic domains.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mutations in genes encoding presenilins (PS1 and PS2)1 cosegregate with the vast majority of pedigrees with early-onset familial Alzheimer's disease (FAD) (1). Multiple lines of evidence indicate that PS expression is essential for intramembranous "gamma -secretase" processing of a number of type I membrane proteins, including the beta -amyloid precursor protein (APP) (2, 3), the developmental signaling receptor, Notch1 (4, 5), the receptor tyrosine kinase, ErbB4 (6), cell adhesion molecules, N- and E-cadherins (7), the low density lipoprotein receptor-related protein, LRP (8), the cell surface adhesion protein, CD44 (9), and the synaptic adhesion protein, nectin-1alpha (10).

The Notch signaling pathway is an evolutionarily conserved signal pathway for local cell-cell communication between neighboring cells involved in cell fate determination (11). The Notch receptors undergo proteolytic processing in the trans-Golgi network by a furin-like convertase in the ectodomain (12), resulting in a mature heterodimeric receptor that accumulates on the cell surface (13). Ligand binding triggers sequential proteolytic processing within the extracellular juxtamembrane region by a member of the ADAM (a disintegrin and metalloprotease domain) family, termed TACE (tumor necrosis factor (TNF)alpha -converting enzyme) (14, 15), and subsequent intramembranous cleavage of this membrane-tethered derivative, termed S2/NEXT, by a PS-dependent gamma -secretase activity (4). The resulting soluble cytoplasmic domain, termed S3/NICD (Notch intracellular domain), translocates to the nucleus and interacts with the DNA-binding proteins CSL, resulting in transcriptional activation of target genes (16, 17).

Several Notch ligands have been identified in vertebrates and invertebrates, including Delta, Serrate, and Jagged, transmembrane proteins that share several structural features including a DSL (Delta, Serrate, Lag-2) domain, required for Notch binding, and multiple epidermal growth factor-like repeats in respective extracellular domains (18, 19). Like Notch, Delta is a substrate for proteolysis by a metalloprotease of the ADAM family, termed Kuzbanian (20), resulting in shedding of the ectodomain segment. The precise role of Kuzbanian-dependent proteolytic processing of Delta is not fully understood, but recent studies suggest that this event down-regulates Delta-mediated Notch signaling (21). In this regard, ectodomain shedding of Jagged has not been described to date.

In this report, we demonstrate that like Notch, Delta1 and Jagged2, are subject to presenilin (PS)-dependent, gamma -secretase processing, resulting in the production of soluble intracellular derivatives. We show that a plasma membrane-resident ~40 kDa carboxyl-terminal fragment (CTF) that is presumably generated by a Kuzbanian-like activity serves as substrate for gamma -secretase, resulting in the liberation of a cytosolic, ~38-kDa CTF. We demonstrate that expression of a Delta1-Gal4VP16 chimera is capable of activating transcription of a luciferase reporter and that nuclear transactivation is abrogated by a highly potent and selective gamma -secretase inhibitor. In parallel, we demonstrate that a ~27-kDa Jagged2 CTF is also a substrate for gamma -secretase. Our findings suggest that Delta1 and Jagged2 may play dual roles as activators of Notch receptor signaling and as receptors that mediate nuclear signaling events via gamma -secretase-generated cytoplasmic domains. Finally, we report that expression of FAD-linked PS1 variants lead to compromised intramembranous cleavage of Delta1. These observations mimic earlier studies showing reduced cleavage at the Notch S3 site and the APP "epsilon " site within respective transmembrane domains in cells expressing FAD-linked mutant PS1. Thus, we argue that a similar molecular apparatus is responsible for intramembranous cleavage of Notch and it's ligand, Delta1.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture and Inhibitor Treatment-- Mouse neuroblastoma N2a cells stably expressing mouse Delta1 and NIH 3T3 cells stably expressing human Jagged2 with a COOH-terminal Myc-epitope tag, were maintained in 200 µg/ml G418 (Invitrogen) and 2.5 µg/ml puromycin (Clontech), respectively. gamma -Secretase inhibitor treatments were for 16 h with 2 µM of L-685,458 (22).

Transfections-- Mouse N2a cells constitutively expressing Myc-epitope Swedish APP695 (23) were cotransfected with 10 µg of PS1 cDNAs and 100 ng of pIREShyg (Clontech) and selected with 400 µg/ml hygromycin. Hygromycin-resistant colonies were further screened with 400 µg/ml of zeocin to generate a stable "pool" of ~100-200 colonies.

Antibodies and Western Blot Analysis-- Cells were lysed in immunoprecipitation buffer containing detergents and protease inhibitors as described (24). Solubilized proteins were fractionated by electrophoresis on SDS-polyacrylamide gels and electrophoretically transferred to polyvinylidene difluoride membranes (Bio-Rad). Membranes were blocked and then probed with primary antibodies and horseradish peroxidase-coupled secondary antibodies (Pierce). Myc-tagged Delta1 and Jagged2 derivatives were detected using monoclonal Myc specific antibody, 9E10. Polyclonal antibody, PS1NT (25), was used to detect full-length PS1 and PS1 NH2-terminal fragment. beta -Tubulin was detected by anti-beta -Tubulin antibody (Sigma). Bound antibodies were visualized by enhanced chemiluminescence (ECL) detection system (PerkinElmer Life Science).

Cell Surface Biotinylation-- Cells were grown to near confluence in a 10-cm dish and subjected to cell surface biotinylation with 0.5 mg/ml sulfosuccinimodobiotin (Sulfo-NHS-SS-biotin, Pierce) essentially as described previously (24). Cells were then lysed in immunoprecipitation buffer, and biotinylated proteins were captured with streptavidin-agarose beads (Pierce).

Luciferase Reporter Assay-- To generate a construct encoding the Delta1-Gal4VP16 fusion protein, the primer pairs, 5'-CCATCGATTTAAGAAGCTACTGTCTTCTATC-3' and 5'-CCATCGATCACCGTCCTCGTCAATTCC-3', were incubated with pMst-GV-APP (26) in a PCR. The PCR product was inserted between the Delta1 COOH terminus and Myc sequences. 0.4 µg of the resulting Delta1-Gal4VP16-Myc construct was cotransfected the Gal4 reporter plasmid (pG5E1B-luci) (26), and 50 ng of a control plasmid encoding Rellina luciferase into HEK293 cells. Cells were harvested 48 h after transfection, and luciferase activities were determined using dual-luciferase reporter assay system (Promega) following manufacture's instructions. Values shown are the averages from triplicate experiments for each condition.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The family of Notch receptors and Notch ligands are type I integral membrane proteins. It is now well established that Notch and the Notch ligand, Delta1, are substrates for processing by metalloproteases of the TACE/ADAM family (14, 15, 20), resulting in shedding of respective ectodomains. In the case of Notch, TACE cleavage generates a membrane-tethered derivative, termed S2/NEXT, that is the substrate for intramembranous proteolysis by a presenilin-dependent gamma -secretase activity (4). This cleavage event, termed S3 cleavage, occurs between amino acids 1743 and 1744 (16); the P1 valine residue is indispensable for S3 cleavage and subsequent nuclear signaling activity (16). Intramembranous cleavage at the S3 site results in the generation of a soluble, cytoplasmic derivative of Notch, termed S3/NICD, that is a transcriptional coactivator. Intrigued by the finding that Delta1 undergoes ectodomain shedding, and the presence of valine residues at analogous positions within the transmembrane domains of Delta1 and the Jagged2 (Fig. 1A), we asked whether these Notch ligands may be substrates for gamma -secretase cleavage, as well.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 1.   PS-dependent gamma -secretase cleavage of Notch ligands. A, amino acid sequences of transmembrane domain and intracellular juxtamembrane region in Notch1 and Notch ligands, Delta1 and Jagged2, are presented. The box represents the predicted transmembrane domain. Mouse Notch1 is cleaved in a PS-dependent manner at S3 site (arrow) before valine 1744 (16). Arrowheads point to valine residue(s) within the Delta1 and Jagged2 transmembrane domains. B, N2a cells stably expressing Myc-tagged mouse Delta1 were incubated in the absence (lane 1) or the presence (lane 2) of gamma -secretase inhibitor, L-685,459. Additionally, we transiently transfected N2a-pooled cells stably expressing human wild-type (WT) PS1 (lane 3) or PS1 D385A variant (lane 4) with cDNA encoding Delta1-Myc. The bands corresponding to ~117-kDa full-length, ~40-kDa COOH-terminal fragment (CTF1), and ~38-kDa CTF2 of Delta1, are indicated (upper panels). The bands corresponding to ~45-kDa full-length PS1 and ~29-kDa PS1 NH2-terminal fragment are also indicated (lower panel). Molecular markers (in kilodaltons) are shown at right. C, NIH 3T3 cells stably expressing Myc-tagged human Jagged2 were incubated in the absence (lane 1) or the presence (lane 2) of L-685,458. We also transfected N2a stable pools expressing PS1 WT (lane 3) or PS1 D385A (lane 4) with cDNA encoding Jagged2-Myc. The band corresponding to ~170-kDa full-length Jagged2 and ~27-kDa CTF1, and ~25-kDa CTF2 of Jagged2 derivatives, are indicated with arrows.

We first examined stable N2a cells that constitutively express Myc-tagged mouse Delta1 harboring a carboxyl-terminal, Myc-epitope tag. Western blot analysis revealed the presence of full-length ~117-kDa Delta1-Myc and a prominent ~40-kDa Delta1 carboxyl-terminal fragment (D-CTF1) that presumably represents the membrane-tethered fragment generated following metalloprotease cleavage within the ectodomain (20, 21) (Fig. 1B, lane 1). In addition, we observed low levels of a ~38-kDa CTF (D-CTF2) at steady state (Fig. 1B, lane 1). Importantly, the ~38-kDa D-CTF2 derivative fails to accumulate in cells treated with a highly potent and selective gamma -secretase inhibitor, L-685,458 (Fig. 1B, lane 2), findings strongly suggesting that this fragments is generated by gamma -secretase. To further establish that production of D-CTF2 is PS-dependent, we transiently expressed Delta1-Myc in N2a cells that constitutively express either wild-type human PS1 or a dominant negative human PS1 variant that harbors the D385A mutation (24); intramembranous processing of Notch1 is abrogated in cells expressing PS1 D385A (24). As we had observed in cells treated with the gamma -secretase inhibitor, D-CTF2 failed to accumulate in cells expressing PS1 D385A (Fig. 2B, lane 4). Collectively, these data strongly suggest that Delta1 is a substrate of PS-dependent, gamma -secretase cleavage.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   Characterization of DICD. A, cell were incubated in borate buffer alone (lanes 1 and 4) or borate buffer containing sulfosuccinimodobiotin (lanes 2, 3, 5, and 6) at 4 °C. Biotinylated surface proteins were captured with streptavidin-agarose beads and detected with Myc-specific, 9E10 antibody. One-twentieth of the lysates used for precipitation were loaded for comparison (lanes 1-4). B, HEK293 cells were cotransfected with cDNAs including Gal4VP16 reporter plasmid, Delta1-Gal4VP16 fusion construct, and an internal control plasmid encoding Renilla luciferase. Values normalized by Renilla luciferase activity to standardize transfection efficiency were shown as the averages (±S.E.) of triplicate samples.

We then examined the processing of the Notch ligand, Jagged2, in an NIH 3T3 cell line that stably expresses human Jagged2 harboring a carboxyl-terminal Myc-epitope tag. Western blot analysis revealed the presence of ~170-kDa full-length Jagged2 and an ~25-kDa Jagged2 carboxyl-terminal fragment (J-CTF2) (Fig. 1C, lane 1). However, the ~25-kDa CTF2 was eliminated in cells treated with the gamma -secretase inhibitor, L-685,458, and interestingly, a new ~27-kDa J-CTF1 accumulates under these conditions (Fig. 1C, lane 2). These findings suggest that J-CTF1 is constitutively processed by a gamma -secretase-like activity, to generate J-CTF2. To establish that production of J-CTF2 is PS-dependent, we transiently expressed Jagged2-Myc into N2a cells that express the PS1 D385A mutation (24). As we had observed in cells treated with the gamma -secretase inhibitor, the production of J-CTF2 is eliminated, and J-CTF1 now accumulates (Fig. 1C, lane 4). These results indicate that Jagged2 is also a substrate of PS-dependent gamma -secretase cleavage.

To identify the subcellular site(s) at which the D-CTF2 and D-CTF1 derivatives of Delta1-Myc accumulate, we treated N2a cells that constitutively express Delta1-Myc with the membrane-impermeant, biotinylation reagent, sulfosuccinimidobiotin at 4 °C. Biotinylated, cell surface polypeptides were recovered from detergent-solubilized lysates using streptavidin-conjugated agarose, and captured proteins were subject to Western blot analysis with the Myc-specific, 9E10 antibody. In cells expressing Delta1-Myc, we observed biotinylated full-length Delta1-Myc and ~40-kDa D-CTF1 (Fig. 2A, lane 5). However, the ~38-kDa D-CTF2 was not recovered by immobilized streptavidin, despite the presence of the fragment in detergent lysates (Fig. 2A, lane 2). Hence, D-CTF2, like the Notch S3/NICD derivative is not present at the cell surface, but presumably present in the cytosol. Moreover, D-CTF2 failed to accumulate in cells treated with the gamma -secretase inhibitor, as expected, and streptavidin only recovered both full-length and ~40-kDa D-CTF1 from detergent lysates of these inhibitor-treated cells (Fig. 2A, lane 6). These observations strongly suggest that the soluble, cytoplasmic domain of Delta1 is generated following sequential cleavage of full-length Delta1 species by the concerted action of Kuzbanian-like metalloprotease(s) and a PS-dependent gamma -secretase.

It is now clear that the soluble intracellular domains of Notch and APP that are generated by gamma -secretase are translocated to the nucleus and serve as transcriptional coactivators (16, 17, 26). To test the possibility that D-CTF2 could be transported to nucleus, and exhibit nuclear signaling activity, we generated cDNA encoding a Delta1-Gal4VP16 fusion protein and transfected this construct into human embryonic kidney 293 (HEK293) cells together with the reporter plasmid, pG5E1B-luciferase (26). Compared with cells expressing the pG5E1B vector, expression of Delta1-Gal4VP16 fusion protein stimulated transcription by ~70-fold (Fig. 2B). Notably, transactivation of the reporter plasmid by the Delta1-Gal4VP16 fusion protein was markedly inhibited upon treatment of cells with the gamma -secretase inhibitor (Fig. 2B). These results suggest that intracellular domain of Delta1 that is generated by PS-dependent gamma -secretase cleavage can be transported into nucleus, findings that raise the possibility that the cytosolic derivative of Delta1 may play a role in nuclear signaling events.

Finally, and intrigued by the finding that cells expressing FAD-linked PS1 mutants enhance production of pathogenic beta -amyloid 42 peptides (1), but exhibit impaired processing within the transmembrane domains of Notch and APP that liberate NICD and AICD, respectively (27-29), we analyzed processing of Delta1-Myc in pools of N2a cells that constitutively express human wild-type PS1 or the PS1 Delta E9, M146L, E280A, or C410Y FAD variants. Compared with N2a cells expressing wild-type human PS1 (Fig. 3A, lane 1), in which Delta1-Myc was processed to D-CTF1 and low levels of D-CTF2, as described above (Fig. 1B), the production of the D-CTF2 fragment is reduced in most cell lines expressing FAD-linked PS1 variants, albeit with only a modest effect in the M146L cells (Fig. 3A, lanes 2-5, quantified in Fig. 3B), this despite comparable levels of expression of human PS1 (Fig. 3A, lower panel). Taken together with the curious observation that expression of FAD-linked PS1 variants leads to reduced processing at the Notch S3 and APP epsilon  sites, our findings that production of the D-CTF2 derived from Delta1 is also reduced by expression of mutant PS1 argues that a similar, if not identical, molecular apparatus is involved in substrate recognition and intramembranous processing of these functionally divergent membrane proteins.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of FAD-linked PS1 mutants on Delta1 gamma -secretase cleavage. A, N2a-pooled cells stably expressing human wild-type (WT) PS1 (lane 1), FAD-linked PS1 Delta E9 mutant (lane 2), M146L (lane 3), E280A (lane 4), or C410Y (lane 5) were transiently transfected with cDNA encoding Delta1-Myc. Delta1 (upper panel) and PS1 (lower panel) derivatives were visualized by immunoblotting with 9E10 and PS1NT, respectively. B, the CTF2 (DICD)/CTF1 ratios of Delta1 were determined by quantifying band intensities using Densitometry (Molecular Probe) and normalized to the PS1 WT value of 100%.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A wealth of evidence has emerged to support a role for PS in intramembranous gamma -secretase processing of a host of type I membrane proteins. Intrigued by the similarity in the amino acid sequence of the transmembrane domains of Notch and it's ligands, Delta and Jagged, we hypothesized that these ligands might also serve as substrates for gamma -secretase. In the present report, we confirm our prediction and offer several insights relevant to the molecular apparatus responsible for intramembranous processing of Delta1 and Jagged2 and the potential functional significance of this processing event.

First, we demonstrate that the production of cytosolic derivatives of Delta1 and Jagged2, termed DICD and JICD, respectively, are inhibited either by a highly potent, and selective transition-state isostere of gamma -secretase activity or by expression of the dominant negative D385A PS1 mutant. Thus, the Notch ligands, Delta1 and Jagged2, are novel substrates of PS-dependent gamma -secretase processing.

Second, and in view of earlier demonstrations that FAD-linked PS1 mutations impair cleavage at the Notch S3 and APP epsilon  sites that lead to production of S3/NICD and AICD (27-29), respectively, we assessed the effects of FAD-linked PS1 variants on gamma -secretase processing of Delta1. We show that the generation of DICD is impaired in most of cell lines stably expressing four independent FAD-linked PS1 mutants. Most interestingly, the relative levels of reduction in DICD parallel the reported effects on S3/NICD production (29); expression of the C410Y variant has the most pronounced effect, while the M146L variant has only a modest effect on gamma -secretase processing. Thus, we argue that the molecular apparatus involved in production of NICD, AICD, and DICD are similar, if not one in the same.

Third, and in view of earlier conclusions that the intracellular domains of Notch (S3/NICD) and APP (AICD) are transcriptional coactivators (16, 17, 24), we hypothesized that gamma -secretase-generated DICD could be translocated to the nucleus and activate transcription of a reporter gene. Our present results support this prediction. Despite the strengths of these observations, the factors responsible for translocating DICD into the nucleus are not known. For the APP derivative, AICD, a cytosolic adaptor protein, Fe65, promotes nuclear translocation (24). For Notch1, three putative nuclear localization signals (NLS) are present within the ICD, and these may serve as recognition motifs by members of the importin/karyopherin alpha  and beta  receptors involved in nuclear import. Similarly, the Delta1 intracellular domain contains two putative NLSs, PDRKRPE at amino acids 686-692, and RKRP at amino acids 688-691, while the Jagged2 intracellular domain contains putative NLSs RKRR at amino acids 1107-1110, and KRRK at 1108-1111. Hence, it is conceivable that DICD and JICD may be imported via the classical importin pathway, but further mutagenesis studies of the putative NLSs will be required to validate this hypothesis.

In any event, our results offer the suggestion that PS-dependent gamma -secretase processing of Delta1 or Jagged2 and production of DICD and JICD may play roles in activating nuclear transcriptional events. While the significance of these findings in relation to cell-intrinsic versus cell-extrinsic aspects of Notch signaling remains to be determined, the proposal that the Notch ligands, Delta1 and Jagged2, may perform roles both as ligands and receptors that directly participate in transcriptional activation warrants further investigation.

    ACKNOWLEDGEMENTS

We are grateful to Drs. J. S. Nye and J. Sklar for providing cell lines expressing Delta1 and Jagged2, respectively.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants AG021494 (to S. S. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of research fellowships from Uehara Memorial Foundation.

§ To whom correspondence should be addressed: Center for Molecular Neurobiology, The University of Chicago, Abbott 510, 947 East 58th St., Chicago, IL 60637. Tel.: 773-834-9186; Fax: 773-834-5311; E-mail: ssisodia@drugs.bsd.uchicago.edu.

Published, JBC Papers in Press, January 24, 2003, DOI 10.1074/jbc.C200711200

    ABBREVIATIONS

The abbreviations used are: PS, presenilin; FAD, familial Alzheimer's disease; APP, beta -amyloid precursor protein; ADAM, a disintegrin and metalloprotease domain; NEXT, Notch extracellular truncation; NICD, Notch intracellular domain; CTF, COOH-terminal fragment; DICD, Delta1 intracellular domain; JICD, Jagged intracellular domain; AICD, APP intracellular domain; NLS, nuclear localization signal.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Price, D. L., Tanzi, R. E., Borchelt, D. R., and Sisodia, S. S. (1998) Annu. Rev. Genet. 32, 461-493[CrossRef][Medline] [Order article via Infotrieve]
2. De Strooper, B., Satig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., and Van Leuven, F. (1998) Nature 391, 387-390[CrossRef][Medline] [Order article via Infotrieve]
3. Naruse, S., Thinakaran, G., Luo, J. J., Kusiak, J. W., Tomita, T., Iwstsubo, T., Qian, X., Ginty, D. D., Price, D. L., Borchelt, D. R., Wong, P. C., and Sisodia, S. S. (1998) Neuron 21, 1213-1221[Medline] [Order article via Infotrieve]
4. De Strooper, B., Annaertm, W., Cuper, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijver, V., Wolfe, M. S., Ray, W. J., Goate, A., and Kopan, R. (1999) Nature 398, 518-522[CrossRef][Medline] [Order article via Infotrieve]
5. Struhl, G., and Greenwald, I. (1999) Nature 398, 522-525[CrossRef][Medline] [Order article via Infotrieve]
6. Ni, C.-Y., Murphy, M. P., Golde, T. E., and Carpenter, G. (2000) Science 294, 2179-2181[Abstract/Free Full Text]
7. Marambaud, P., Shioi, J., Serban, G., Georgakopoulos, A., Sarner, S., Nagy, V., Biki, L., Wen, P., Efthimiopoulos, S., Shao, Z., Wisniewski, T., and Robakis, N. K. (2002) EMBO J. 21, 1948-1956[Abstract/Free Full Text]
8. May, P., Reddy, Y. K., and Herz, J. (2002) J. Biol. Chem. 277, 18736-18743[Abstract/Free Full Text]
9. Lammich, S., Okochi, M., Takeda, M., Kaether, C., Capell, A., Zimmer, A.-K., Edbauer, D., Walter, J., Steiner, H., and Haass, C. (2002) J. Biol. Chem. 277, 44754-44759[Abstract/Free Full Text]
10. Kim, D. Y., MacKenzie Ingano, L. A., and Kovacs, D. M. (2002) J. Biol. Chem. 277, 49976-49981[Abstract/Free Full Text]
11. Artavanis-Tsakonas, S., Rand, M. D., and Lake, R. J. (1999) Science 284, 770-776[Abstract/Free Full Text]
12. Logeat, F., Bessia, C., Brou, C., LeBail, O., Jarriault, S., Seiday, N., and Israel, A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8108-8112[Abstract/Free Full Text]
13. Blaumueller, C. M., Qi, H., Zagoukas, P., and Artavanis-Tsakonas, S. (1997) Cell 90, 281-291[Medline] [Order article via Infotrieve]
14. Brou, C., Logeat, F., Gupta, N., Bessia, C., LeBail, O., Doedens, J. R., Cumano, A., Roux, P., Black, R. A., and Israel, A. (2000) Mol. Cell 5, 207-216[Medline] [Order article via Infotrieve]
15. Mumm, J. S., Schroeter, E. H., Saxena, M. T., Griesemer, A., Tian, X., Pan, D. J., Ray, W. J., and Kopan, R. (2000) Mol. Cell 5, 197-206[Medline] [Order article via Infotrieve]
16. Schroeter, E. H., Kisslinger, J. A., and Kopan, R. (1998) Nature 393, 382-386[CrossRef][Medline] [Order article via Infotrieve]
17. Struhl, G., and Adachi, A. (1998) Cell 93, 649-660[Medline] [Order article via Infotrieve]
18. Grace, G. E., Mann, R. S., Mitsiadis, E., Henrique, D., Carcangiu, M.-L., Banks, A., Leiman, J., Ward, D., Ish-Horowitz, D., and Artavanis-Tsakonas, A. (1999) Am. J. Pathol. 165, 785-794
19. Lindsell, C. E., Shawber, C. J., Boulter, J., and Weinmaster, G. (1995) Cell 80, 909-917[Medline] [Order article via Infotrieve]
20. Qi, H., Rand, M. D., Wu, X., Sestan, N., Wang, W., Rakic, P., Xu, T., and Artavanis-Tsakonas, S. (1999) Science 283, 91-94[Abstract/Free Full Text]
21. Mishra-Gorur, K., Rand, M. D., Perez-Villamil, B., and Artavanis-Tsakonas, S. (2002) J. Cell Biol. 159, 313-324[Abstract/Free Full Text]
22. Shearman, M. S., Beher, D., Clark, E. E., Lewis, H. D., Harrison, T., Hunt, P., Nadin, A., Smith, A. L., Stevenson, G., and Castro, J. L. (2000) Biochemistry 39, 8698-8704[CrossRef][Medline] [Order article via Infotrieve]
23. Thinakaran, G., Harris, C. L., Ratovitski, T., Davenport, F., Slunt, H. H., Price, D. L., Borchelt, D. R., and Sisodia, S. S. (1997) J. Biol. Chem. 272, 28415-28422[Abstract/Free Full Text]
24. Kim, S.-H., Leem, J. Y., Lah, J. J., Slunt, H. H., Levey, A. I., Thinakaran, G., and Sisodia, S. S. (2001) J. Biol. Chem. 276, 43343-43350[Abstract/Free Full Text]
25. Thinakaran, G., Getard, F. B., Bouton, C. M. L., Harris, C. L., Price, D. L., Borchelt, D. R., and Sisodia, S. S. (1998) Neurobiol. Dis. 4, 438-453[CrossRef][Medline] [Order article via Infotrieve]
26. Cao, X., and Südhof, T. (2001) Science 293, 115-120[Abstract/Free Full Text]
27. Moehlmann, T., Winkler, E., Xia, X., Edbauer, D., Murrell, J., Capell, A., Kaether, C., Zheng, H., Ghetti, B., Haass, C., and Steiner, H. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 8025-8030[Abstract/Free Full Text]
28. Chen, F., Gu, Y. J., Hasegawa, H., Ruan, X., Arawaka, S., Fraser, P., Westaway, D., Mount, H., and St. George-Hyslop, P. (2002) J. Biol. Chem. 277, 36521-36526[Abstract/Free Full Text]
29. Song, W., Nadeau, P., Yuan, M., Yang, X., Shen, J., and Yankner, B. A. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 6959-6963[Abstract/Free Full Text]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.